4169 — Tcm Biotech International Share Price
0.000.00%
Last trade - 00:00- TWD9.30bn
- TWD8.79bn
- TWD685.49m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 8.81 | ||
| Price to Tang. Book | 8.96 | ||
| Price to Free Cashflow | 271.12 | ||
| Price to Sales | 13.57 | ||
| EV to EBITDA | 208.44 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.71% | ||
| Return on Equity | 1.81% | ||
| Operating Margin | 2.72% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 702.05 | 802.42 | 969.62 | 666.53 | 685.49 | n/a | n/a | -1.44% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -95.45 | +1513.38 | -1.94 | +1.57 | -5.99 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
TCM BIOTECH INTERNATIONAL CORP. is a Taiwan-based company principally engaged in the detection and development of new medicine for liver disease. The Company’s main businesses include the development of new medicine, which are mainly used for the treatment of hepatitis C and non-alcoholic fatty liver and other disease, manufacture and sales of dietary supplements and botanical raw materials, the sales of western medicine products and medical equipment, which are mainly used for the treatment of orthopedic disorders, cardiovascular disorders, oncology disorders and others, sales agent of organic products. The Company distributes its products both in domestic markets and to overseas markets.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- February 20th, 1998
- Public Since
- May 7th, 2012
- No. of Employees
- 73
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 59,048,000
- Address
- 7F, No. 11, Lane 35,, TAIPEI, 221
- Web
- https://www.tcmbio.com/tw/
- Phone
- +886 226972628
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for 4169
Similar to 4169
Adimmune
Taiwan Stock Exchange
Bora Pharmaceuticals Co
Taiwan Stock Exchange
BRIM Biotechnology
Taiwan Stock Exchange
Caliway Biopharmaceuticals Co
Taiwan Stock Exchange
Cenra
Taiwan Stock Exchange
FAQ
What is the Tcm Biotech International share price?
As of Today at 05:36 UTC, shares in Tcm Biotech International are trading at TWD157.50. This share price information is delayed by 15 minutes.
How has the Tcm Biotech International share price performed this year?
Shares in Tcm Biotech International last closed at TWD157.50 and the price had moved by +196.05% over the past 365 days. In terms of relative price strength the Tcm Biotech International share price has outperformed the FTSE Developed Asia Pacific Index by +71.88% over the past year.
What are the analyst and broker recommendations for Tcm Biotech International?
There is no consensus recommendation for this security.
Find out moreWhat is the Tcm Biotech International dividend yield?
The Tcm Biotech International dividend yield is 0.23% based on the trailing twelve month period.
Does Tcm Biotech International pay a dividend?
Last year, Tcm Biotech International paid a total dividend of TWD0.36, and it currently has a trailing dividend yield of 0.23%. We do not have any data on when Tcm Biotech International is to next pay dividends.
When does Tcm Biotech International next pay dividends?
We do not have data on when Tcm Biotech International is to next pay dividends. The historic dividend yield on Tcm Biotech International shares is currently 0.23%.
How do I buy Tcm Biotech International shares?
To buy shares in Tcm Biotech International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Tcm Biotech International?
As of the previous close price of TWD157.50, shares in Tcm Biotech International had a market capitalisation of TWD9.30bn.
Where are Tcm Biotech International shares listed?
Here are the trading details for Tcm Biotech International:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 4169
What kind of share is Tcm Biotech International?
Based on an overall assessment of its quality, value and momentum Tcm Biotech International is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Tcm Biotech International share price forecast for 2026?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Tcm Biotech International share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tcm Biotech International. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -5.55%.
As of the last closing price of TWD157.50, shares in Tcm Biotech International were trading +12.58% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Tcm Biotech International PE Ratio?
The Tcm Biotech International PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD157.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Tcm Biotech International?
We do not have data on Tcm Biotech International's directors